331 related articles for article (PubMed ID: 9353155)
21. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.
Hermann R; Laine AP; Veijola R; Vahlberg T; Simell S; Lähde J; Simell O; Knip M; Ilonen J
Diabetologia; 2005 Sep; 48(9):1766-75. PubMed ID: 16025255
[TBL] [Abstract][Full Text] [Related]
22. [Genetic and humoral autoimmunity markers of type 1 diabetes: from theory to practice].
Silva ME; Mory D; Davini E
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):166-80. PubMed ID: 18438527
[TBL] [Abstract][Full Text] [Related]
23. CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect.
Fajardy I; Vambergue A; Stuckens C; Weill J; Danze PM; Fontaine P
Eur J Immunogenet; 2002 Jun; 29(3):251-7. PubMed ID: 12047362
[TBL] [Abstract][Full Text] [Related]
24. Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus.
Hayashi H; Kusaka I; Nagasaka S; Kawakami A; Rokkaku K; Nakamura T; Saito T; Higashiyama M; Honda K; Ishikawa SE
Clin Endocrinol (Oxf); 1999 Dec; 51(6):793-9. PubMed ID: 10619986
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
26. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
27. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults.
Cosentino A; Gambelunghe G; Tortoioli C; Falorni A
Ann N Y Acad Sci; 2002 Apr; 958():337-40. PubMed ID: 12021137
[TBL] [Abstract][Full Text] [Related]
28. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
[TBL] [Abstract][Full Text] [Related]
29. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?
Steck AK; Zhang W; Bugawan TL; Barriga KJ; Blair A; Erlich HA; Eisenbarth GS; Norris JM; Rewers MJ
Diabetes; 2009 Apr; 58(4):1028-33. PubMed ID: 19188433
[TBL] [Abstract][Full Text] [Related]
30. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8.
Sanjeevi CB; Hagopian WA; Landin-Olsson M; Kockum I; Woo W; Palmer JP; Lernmark A; Dahlquist G
Tissue Antigens; 1998 Mar; 51(3):281-6. PubMed ID: 9550329
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
32. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry.
Nisticò L; Buzzetti R; Pritchard LE; Van der Auwera B; Giovannini C; Bosi E; Larrad MT; Rios MS; Chow CC; Cockram CS; Jacobs K; Mijovic C; Bain SC; Barnett AH; Vandewalle CL; Schuit F; Gorus FK; Tosi R; Pozzilli P; Todd JA
Hum Mol Genet; 1996 Jul; 5(7):1075-80. PubMed ID: 8817351
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.
Golden B; Levin L; Ban Y; Concepcion E; Greenberg DA; Tomer Y
J Clin Endocrinol Metab; 2005 Aug; 90(8):4904-11. PubMed ID: 15928253
[TBL] [Abstract][Full Text] [Related]
34. 5' insulin gene polymorphism confers risk to IDDM independently of HLA class II susceptibility.
van der Auwera BJ; Heimberg H; Schrevens AF; van Waeyenberge C; Flament J; Schuit FC
Diabetes; 1993 Jun; 42(6):851-4. PubMed ID: 8495808
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.
Sarugeri E; Dozio N; Belloni C; Meschi F; Pastore MR; Bonifacio E
Clin Exp Immunol; 1998 Dec; 114(3):370-6. PubMed ID: 9844045
[TBL] [Abstract][Full Text] [Related]
36. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes.
Abe T; Takino H; Yamasaki H; Ozaki M; Sera Y; Kondo H; Sakamaki H; Kawasaki E; Awata T; Yamaguchi Y; Eguchi K
Diabetes Res Clin Pract; 1999 Nov; 46(2):169-75. PubMed ID: 10724097
[TBL] [Abstract][Full Text] [Related]
37. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
[TBL] [Abstract][Full Text] [Related]
38. HLA-DQB1 genotypes and islet cell antibodies in the identification of siblings at risk for insulin-dependent diabetes (IDDM) in Finland. Childhood Diabetes in Finland (DiMe) Study Group.
Reijonen H; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
J Autoimmun; 1994 Oct; 7(5):675-86. PubMed ID: 7840859
[TBL] [Abstract][Full Text] [Related]
39. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
